Bulk amorphous Fe 65.5 Cr 4 Mo 4 Ga 4 P 12 C 5 B 5.5 rods with diameters of 1.5-3 mm were prepared by copper mold casting. Besides casting, bulk amorphous Fe 77 Al 2.14 Ga 0.86 P 8.4 C 5 B 4 Si 2.6 samples in the shape of discs (diameter of 10 mm and thickness of 3 mm) were prepared from melt-spun ribbons by high-energy ball milling and subsequent compaction of the resulting powders in the supercooled liquid region. The ascast amorphous FeCrMoGaPCB samples exhibit a low coercivity, below 10 A·m −1 . In the case of the FeAlGaPCBSi alloy, the milling-induced stress causes significant differences in coercivity between the ribbons and the powders. The relatively low coercivity of about 5-10 A·m −1 characteristic for the melt-spun ribbons increases after 1 hour of ball milling to a value of about 2200 A·m −1 . Subsequent annealing of the ball-milled powders leads to a decrease of H c by a factor of 10 to about 220-250 A·m −1 . The bulk samples prepared by hot pressing of the crushed ribbons show a coercivity of about 120-140 A·m −1 . For both alloys, thermal stability measurements show a distinct glass transition, followed by a supercooled liquid region of 60 K for Fe 65.5 Cr 4 Mo 4 Ga 4 P 12 C 5 B 5.5 and of 30 K for Fe 77 Al 2.14 Ga 0.86 P 8.4 C 5 B 4 Si 2.6 . For the Fe 65.5 Cr 4 Mo 4 Ga 4 P 12 C 5 B 5.5 alloy, crystallization of the amorphous phase as observed by in-situ X-ray diffraction measurements in transmission configuration occurs via the formation of a metastable intermediate phase. The phases observed in the crystalline state obtained by heating do not correspond to those occurring after slow cooling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.